ID: ALA5088656

Max Phase: Preclinical

Molecular Formula: C47H54N10O6

Molecular Weight: 855.01

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Nc1nnc(-c2ccccc2O)cc1N1CC2CCC(C1)N2c1cccc(OCCN2CCN(CC3CCN(c4ccc5c(c4)C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)c1

Standard InChI:  InChI=1S/C47H54N10O6/c48-44-41(26-39(50-51-44)37-6-1-2-7-42(37)58)55-28-33-8-9-34(29-55)56(33)32-4-3-5-35(24-32)63-23-22-52-18-20-53(21-19-52)27-30-14-16-54(17-15-30)31-10-11-36-38(25-31)47(62)57(46(36)61)40-12-13-43(59)49-45(40)60/h1-7,10-11,24-26,30,33-34,40,58H,8-9,12-23,27-29H2,(H2,48,51)(H,49,59,60)

Standard InChI Key:  NZXFUHUZHUMMLU-UHFFFAOYSA-N

Associated Targets(Human)

Probable global transcription activator SNF2L2 466 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 855.01Molecular Weight (Monoisotopic): 854.4228AlogP: 3.60#Rotatable Bonds: 11
Polar Surface Area: 181.01Molecular Species: BASEHBA: 14HBD: 3
#RO5 Violations: 2HBA (Lipinski): 16HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.45CX Basic pKa: 8.84CX LogP: 2.99CX LogD: 2.49
Aromatic Rings: 4Heavy Atoms: 63QED Weighted: 0.19Np Likeness Score: -0.77

References

1. Sabnis RW..  (2022)  Bifunctional Compounds as SMARCA2 Degraders for Treating Cancer.,  13  (1.0): [PMID:35059115] [10.1021/acsmedchemlett.1c00657]

Source